Tumor cells in colorectal cancer exploit an important signaling pathway that normally controls embryo development.

KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat.

An anthelminthic drug commonly used for pinworm infections could be repurposed to treat a deadly form of skin cancer, according to early study results.Researchers found pyrvinium pamoate significantly ...

Allarity Therapeutics has announced that it will begin patient enrollment for a new clinical trial protocol of stenoparib, a dual PARP/Wnt pathway inhibitor, aimed at treating advanced ovarian cancer.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

the Wnt pathway could be very promising for the treatment of other diseases.” Today's oncology and eye-focused deals strengthen Roche’s pipeline in two of the five priority areas for its new ...

colorectal cancer and other Wnt-pathway activated (WPAM+) solid tumors. "We’ve made significant leaps forward in the last year in both experimental and data science technologies, propelling us ...

Many components of the Wnt pathway are theoretically targets for new drug discovery. Selecting a tissue-appropriate target may be an important consideration in order to limit toxicity. Targeting ...

dual PARP and WNT pathway inhibitor—today announced the Company’s CEO, Thomas Jensen, will deliver a company overview focused on stenoparib and the Company’s DRP® companion diagnostic ...

SRIHER spine surgery team wins Best International Research Award for groundbreaking research on Wnt signaling pathway in spinal cord injuries.